Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yann De Rycke

Showing results (1-10 of 73) with videos related to

Pageof 8
Sort By:
Journal of Clinical Epidemiology|May 28, 2017
Overfitting in propensity score model: a commentary on "propensity score model overfitting led to inflated variance of estimated odds ratios" by Schuster et alDavid Hajage, Florence Tubach, Yann De Rycke
Plos One|September 15, 2015
A Rescue Strategy for Handling Unevaluable Patients in Simon's Two Stage DesignLisa Belin, Philippe Broët, Yann De Rycke
Contemporary Clinical Trials Communications|April 27, 2018
A two-stage design for phase II trials with time-to-event endpoint using restricted follow-upLisa Belin, Yann De Rycke, Philippe Broët
Statistics in Medicine|July 23, 2013
A model combining excess and relative mortality for population-based studiesCaroline Elie, Paul Landais, Yann De Rycke
Physics in Medicine and Biology|April 24, 2004
Methodology to predict a maximum follow-up period for breast cancer patients without significantly reducing the chance of detecting a local recurrenceRichard F Mould, Bernard Asselain, Yann De Rycke
Statistics in Medicine|November 19, 2016
Estimation of conditional and marginal odds ratios using the prognostic scoreDavid Hajage, Yann De Rycke, Guillaume Chauvet, et al.
Pharmacoepidemiology and Drug Safety|May 10, 2017
Evaluation of algorithms to identify incident cancer cases by using French health administrative databasesAya Ajrouche, Candice Estellat, Yann De Rycke, et al.
British Journal of Cancer|March 28, 2020
Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic reviewLisa Belin, Aidan Tan, Yann De Rycke, et al.
Statistics in Medicine|March 25, 2011
Targeting population entering phase III trials: a new stratified adaptive phase II designCaroline Tournoux-Facon, Yann De Rycke, Pascale Tubert-Bitter
Statistics in Medicine|March 25, 2011
How a new stratified adaptive phase II design could improve targeting populationCaroline Tournoux-Facon, Yann De Rycke, Pascale Tubert-Bitter
Pageof 8

Showing results (1-10 of 73) with videos related to

Sort By:
Pageof 8
Journal of Clinical Epidemiology|May 28, 2017
Overfitting in propensity score model: a commentary on "propensity score model overfitting led to inflated variance of estimated odds ratios" by Schuster et alDavid Hajage, Florence Tubach, Yann De Rycke
Plos One|September 15, 2015
A Rescue Strategy for Handling Unevaluable Patients in Simon's Two Stage DesignLisa Belin, Philippe Broët, Yann De Rycke
Contemporary Clinical Trials Communications|April 27, 2018
A two-stage design for phase II trials with time-to-event endpoint using restricted follow-upLisa Belin, Yann De Rycke, Philippe Broët
Statistics in Medicine|July 23, 2013
A model combining excess and relative mortality for population-based studiesCaroline Elie, Paul Landais, Yann De Rycke
Physics in Medicine and Biology|April 24, 2004
Methodology to predict a maximum follow-up period for breast cancer patients without significantly reducing the chance of detecting a local recurrenceRichard F Mould, Bernard Asselain, Yann De Rycke
Statistics in Medicine|November 19, 2016
Estimation of conditional and marginal odds ratios using the prognostic scoreDavid Hajage, Yann De Rycke, Guillaume Chauvet, et al.
Pharmacoepidemiology and Drug Safety|May 10, 2017
Evaluation of algorithms to identify incident cancer cases by using French health administrative databasesAya Ajrouche, Candice Estellat, Yann De Rycke, et al.
British Journal of Cancer|March 28, 2020
Progression-free survival as a surrogate for overall survival in oncology trials: a methodological systematic reviewLisa Belin, Aidan Tan, Yann De Rycke, et al.
Statistics in Medicine|March 25, 2011
Targeting population entering phase III trials: a new stratified adaptive phase II designCaroline Tournoux-Facon, Yann De Rycke, Pascale Tubert-Bitter
Statistics in Medicine|March 25, 2011
How a new stratified adaptive phase II design could improve targeting populationCaroline Tournoux-Facon, Yann De Rycke, Pascale Tubert-Bitter
Pageof 8